Healthcor Management LP Has Lowered Clovis Oncology (CLVS) Holding By $3.30 Million, Onebeacon Insurance Group Limited Class (OB) Shorts Lowered By 11.6%

June 20, 2017 - By Marie Mckinney

Onebeacon Insurance Group Limited Class (NYSE:OB) had a decrease of 11.6% in short interest. OB’s SI was 145,600 shares in June as released by FINRA. Its down 11.6% from 164,700 shares previously. With 769,200 avg volume, 0 days are for Onebeacon Insurance Group Limited Class (NYSE:OB)’s short sellers to cover OB’s short positions. The SI to Onebeacon Insurance Group Limited Class’s float is 0.66%. It is 0.00% or $0 reaching $18.17 per share. It is down 41.44% since June 20, 2016 and is uptrending. It has outperformed by 24.74% the S&P500.

Healthcor Management Lp decreased Clovis Oncology Inc (CLVS) stake by 10.71% reported in 2016Q4 SEC filing. Healthcor Management Lp sold 75,000 shares as Clovis Oncology Inc (CLVS)’s stock declined 20.61%. The Healthcor Management Lp holds 625,000 shares with $27.76 million value, down from 700,000 last quarter. Clovis Oncology Inc now has $5.90 billion valuation. The stock rose 2.25% or $1.98 reaching $89.86. About 3.92 million shares traded or 101.03% up from the average. Clovis Oncology Inc (NASDAQ:CLVS) has risen 282.71% since June 20, 2016 and is uptrending. It has outperformed by 266.01% the S&P500.

Among 14 analysts covering Clovis Oncology (NASDAQ:CLVS), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Clovis Oncology had 36 analyst reports since September 10, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, January 21 by Credit Suisse. The stock has “Buy” rating by J.P. Morgan on Thursday, June 1. The firm has “Buy” rating given on Thursday, September 10 by WallachBeth Capital. Piper Jaffray maintained it with “Neutral” rating and $28 target in Monday, November 16 report. The stock of Clovis Oncology Inc (NASDAQ:CLVS) has “Sell” rating given on Friday, February 3 by Chardan Capital Markets. The firm has “Neutral” rating given on Monday, June 19 by Chardan Capital Markets. JP Morgan upgraded Clovis Oncology Inc (NASDAQ:CLVS) on Wednesday, May 17 to “Overweight” rating. SunTrust maintained Clovis Oncology Inc (NASDAQ:CLVS) on Friday, September 23 with “Buy” rating. The firm earned “Buy” rating on Wednesday, August 24 by SunTrust. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, September 21.

Since March 15, 2017, it had 0 insider buys, and 3 selling transactions for $528,600 activity. On Thursday, June 15 the insider IVERS-READ GILLIAN C sold $185,460.

Analysts await Clovis Oncology Inc (NASDAQ:CLVS) to report earnings on August, 14. They expect $-1.37 EPS, up 33.82% or $0.70 from last year’s $-2.07 per share. After $-1.33 actual EPS reported by Clovis Oncology Inc for the previous quarter, Wall Street now forecasts 3.01% negative EPS growth.

Investors sentiment decreased to 1.03 in 2016 Q4. Its down 0.97, from 2 in 2016Q3. It dived, as 30 investors sold CLVS shares while 48 reduced holdings. 38 funds opened positions while 42 raised stakes. 35.69 million shares or 2.51% less from 36.61 million shares in 2016Q3 were reported. Cypress Capital Management Limited Liability Corporation (Wy) reported 0% stake. Atika Cap Mngmt Ltd Liability Company holds 1.11% or 42,000 shares. Deutsche Comml Bank Ag reported 126,195 shares stake. Jasper Ridge Prtnrs Ltd Partnership invested in 0.01% or 4,592 shares. Royal Bankshares Of Canada has invested 0% in Clovis Oncology Inc (NASDAQ:CLVS). Moreover, Gp One Trading Limited Partnership has 0% invested in Clovis Oncology Inc (NASDAQ:CLVS). Fifth Third National Bank owns 1,917 shares or 0% of their US portfolio. Jacobs Levy Equity owns 4,700 shares for 0% of their portfolio. Tower Cap (Trc) accumulated 0.02% or 4,493 shares. Westfield Cap Management Co Lp invested in 0.17% or 429,185 shares. Passport Cap Limited Liability Company owns 381,814 shares for 0.28% of their portfolio. Pub Employees Retirement Association Of Colorado has invested 0% in Clovis Oncology Inc (NASDAQ:CLVS). The California-based Blue Jay Cap Mgmt Limited Co has invested 8.01% in Clovis Oncology Inc (NASDAQ:CLVS). Nationwide Fund has 38,385 shares. Blackrock reported 0% of its portfolio in Clovis Oncology Inc (NASDAQ:CLVS).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: